Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508764 · ClinicalTrials.gov registry record · NA
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT04508764 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 96 participants.
The verdict
NCT04508764, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.
Interventions
- OTHER Families Accelerating Cascade Testing Toolkit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2024-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04508764
The ClinicalTrials.gov registry entry for NCT04508764 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Families Accelerating Cascade Testing Toolkit is the first listed.
NCT04508764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04508764 about?
NCT04508764 is a clinical study titled "Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome". The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.
What is the current status of trial NCT04508764?
This trial is currently terminated. It is a NA study. The enrollment target is 96 participants. The study started on 2021-04-09. Estimated completion is 2024-03-20.
What interventions are being tested in trial NCT04508764?
The interventions under investigation include: Families Accelerating Cascade Testing Toolkit (OTHER).
Who is sponsoring clinical trial NCT04508764?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.